Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878)
Titel:
Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878)
Auteur:
Riess, Jonathan W Reckamp, Karen L Frankel, Paul Longmate, Jeffrey Kelly, Karen A Gandara, David R Weipert, Caroline M Raymond, Victoria M Keer, Harold N Mack, Philip C Newman, Edward M Lara Jr., Primo N